INTRONA

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Ireland, Lithuania, Netherlands, Poland, Singapore, United States

Active ingredients

The drug INTRONA contains one active pharmaceutical ingredient (API):

1 Interferon, alfa-2b UNII 43K1W2T1M6 - INTERFERON ALFA-2B

Recombinant interferon alfa-2b is a sterile, stable, formulation of highly purified interferon alfa-2b produced by recombinant DNA techniques. Interferons exert their cellular activities by binding to specific membrane receptors on the cell surface. Recombinant interferon alfa-2b has exhibited antiproliferative effects in studies employing both animal and human cell culture systems as well as human tumour xenografts in animals. It has demonstrated significant immunomodulatory activity in vitro. Read about Interferon, alfa-2b

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INTRONA Solution for injection or infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AB05	Interferon alfa-2b	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02223406, 02238674, 02238675
Country: EE	Ravimiamet	Identifier(s): 1040050, 1040061, 1040072, 1216358, 1216369, 1216370, 1216381, 1216392, 1216404, 1216415, 1216426, 1216437, 1216448, 1216459, 1216460, 1216516, 1216527, 1216538, 1216549, 1216550, 1216561, 1216572, 1216987, 1216998, 1834624, 1834635, 1834646, 1834657, 1834668, 1834679, 1834680, 1834691, 1834703, 1834714, 1834725, 1834736, 1834747, 1834758, 1834769, 1834770, 1834781, 1834792, 1834804
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1013461, 1013466, 1013468, 1028545, 1028546, 1028547, 1028548, 1028549, 1028551, 1028552, 1028553, 1028554, 1028555, 1028556, 1028557, 1028558, 1028559, 1028560, 1028561, 1028563, 1028564, 1028565, 1028566, 1028568, 1028569, 1028570, 1028571, 1028572, 1028573, 1028574, 1028575, 1028576, 1079239, 1079240, 1079241, 1079242, 1079243, 1079244, 1079245, 1079246, 1079247, 1085253
Country: NL	Z-Index G-Standaard	Identifier(s): 14613905
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 136255, 64742
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100126264, 100126270, 100126287, 100126293, 100126301, 100126318, 100126324, 100337771
Country: SG	Health Sciences Authority	Identifier(s): 11010P, 11011P
Country: US	FDA, National Drug Code	Identifier(s): 0085-1133, 0085-1168